2026 Pivotal Phase 3 Readout Calendar
~3000 rows
~900 KB CSV
Updated weekly
Worldwide
2026
Free
Download
About this dataset
All Phase 3 trials registered on ClinicalTrials.gov with a primary completion date in calendar year 2026. Includes sponsor, drug, indication, sample size, primary endpoint, and any posted preliminary results.
Schema
| Column | Description | Type |
|---|---|---|
nct_id | ClinicalTrials.gov NCT identifier | |
brief_title | Trial title | |
lead_sponsor_name | Lead sponsor | |
phase | Trial phase | |
completion_date | Primary completion date (ISO 8601) | |
has_results | Whether results are posted |
Sources
ClinicalTrials.gov.
Citation
APA
Drug Landscape. (2026). 2026 Pivotal Phase 3 Readout Calendar (Version 2026.05) [Data set]. Drug Landscape. https://druglandscape.com/datasets/phase-3-readouts-2026
BibTeX
@dataset{DrugLandscape2026Phase3Readouts,
author = {Drug Landscape},
title = {2026 Pivotal Phase 3 Readout Calendar},
year = {2026},
version = {2026.05},
publisher = {Drug Landscape},
url = {https://druglandscape.com/datasets/phase-3-readouts-2026},
note = {~3000 rows; source: ClinicalTrials.gov}
}
RIS
TY - DATA T1 - 2026 Pivotal Phase 3 Readout Calendar AU - Drug Landscape PY - 2026 ET - 2026.05 PB - Drug Landscape UR - https://druglandscape.com/datasets/phase-3-readouts-2026 ER -
License
Free for any use including commercial, with attribution to Drug Landscape (druglandscape.com). Full terms in our editorial policy.